197 related articles for article (PubMed ID: 32332429)
1. Apolipoprotein C-II: the re-emergence of a forgotten factor.
Wolska A; Reimund M; Remaley AT
Curr Opin Lipidol; 2020 Jun; 31(3):147-153. PubMed ID: 32332429
[TBL] [Abstract][Full Text] [Related]
2. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
Wolska A; Lo L; Sviridov DO; Pourmousa M; Pryor M; Ghosh SS; Kakkar R; Davidson M; Wilson S; Pastor RW; Goldberg IJ; Basu D; Drake SK; Cougnoux A; Wu MJ; Neher SB; Freeman LA; Tang J; Amar M; Devalaraja M; Remaley AT
Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996466
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
Wolska A; Dunbar RL; Freeman LA; Ueda M; Amar MJ; Sviridov DO; Remaley AT
Atherosclerosis; 2017 Dec; 267():49-60. PubMed ID: 29100061
[TBL] [Abstract][Full Text] [Related]
4. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT
J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515
[TBL] [Abstract][Full Text] [Related]
5. Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.
Taskinen MR; Packard CJ; Borén J
Curr Atheroscler Rep; 2019 May; 21(8):27. PubMed ID: 31111320
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach.
Reimund M; Wolska A; Risti R; Wilson S; Sviridov D; Remaley AT; Lookene A
Biochem Biophys Res Commun; 2019 Oct; 519(1):67-72. PubMed ID: 31477272
[TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
10. Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle.
Pulawa LK; Jensen DR; Coates A; Eckel RH
J Lipid Res; 2007 Jan; 48(1):145-51. PubMed ID: 17018885
[TBL] [Abstract][Full Text] [Related]
11. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
[TBL] [Abstract][Full Text] [Related]
12. ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.
Ramms B; Patel S; Nora C; Pessentheiner AR; Chang MW; Green CR; Golden GJ; Secrest P; Krauss RM; Metallo CM; Benner C; Alexander VJ; Witztum JL; Tsimikas S; Esko JD; Gordts PLSM
J Lipid Res; 2019 Aug; 60(8):1379-1395. PubMed ID: 31092690
[TBL] [Abstract][Full Text] [Related]
13. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.
Silbernagel G; Chen YQ; Rief M; Kleber ME; Hoffmann MM; Stojakovic T; Stang A; Sarzynski MA; Bouchard C; März W; Qian YW; Scharnagl H; Konrad RJ
Eur Heart J; 2023 Jul; 44(25):2335-2345. PubMed ID: 37155355
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
15. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
[TBL] [Abstract][Full Text] [Related]
16. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy.
Straat ME; Martinez-Tellez B; Nahon KJ; Janssen LGM; Verhoeven A; van der Zee L; Mulder MT; Kooijman S; Boon MR; van Lennep JER; Cobbaert CM; Giera M; Rensen PCN
J Clin Lipidol; 2022; 16(4):472-482. PubMed ID: 35568684
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
[No Abstract] [Full Text] [Related]
19. Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition.
Meyers NL; Larsson M; Vorrsjö E; Olivecrona G; Small DM
J Lipid Res; 2017 May; 58(5):840-852. PubMed ID: 28159869
[TBL] [Abstract][Full Text] [Related]
20. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.
Kei AA; Filippatos TD; Tsimihodimos V; Elisaf MS
Metabolism; 2012 Jul; 61(7):906-21. PubMed ID: 22304839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
